Summary by Moomoo AI
Eli Lilly and Co officer, Zakrowski Donald A, is set to sell 750 shares of the company's common stock on 03/11/2024, with an aggregate market value of $565,200. The shares were originally acquired on 02/10/2023 as part of a performance share unit award under the issuer's equity compensation plan. This transaction follows a period where no securities were sold by Zakrowski in the past three months, as per the latest filings.